Clinical Trial

International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRE

Study acronym: LIVERMET-IRE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Procedural data will be recorded from patients with liver metastases from colorectal cancer who have received at least one course of systemic chemotherapy and who have been assessed by an appropriately constituted MDT (or equivalent) as appropriate to receive irreversible electroporation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-23.
Trial Details
NCT Number NCT07191548
Lead Sponsor Angiodynamics, Inc.
Conditions Colorectal Adenocarcinoma Metastatic in the Liver, Liver Ablation, Liver Cancer, Adult
Enrollment 50 participants
Start Date 2026-02
Primary Completion 2028-02 (estimated)
Study Completion 2029-02 (estimated)
Updated on ClinicalTrials.gov 2025-10-10